Hexagon Capital Partners’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,137
| Closed | -$18.9K | – | 87 |
|
|
2025
Q1 | $18.9K | Sell |
1,137
-198
| -15% | -$3.29K | ﹤0.01% | 779 |
|
|
2024
Q4 | $24.5K | Buy |
1,335
+4
| +0.3% | +$73 | ﹤0.01% | 719 |
|
|
2024
Q3 | $20.5K | Buy |
1,331
+145
| +12% | +$2.23K | ﹤0.01% | 707 |
|
|
2024
Q2 | $19.3K | Buy |
1,186
+852
| +255% | +$13.8K | ﹤0.01% | 698 |
|
|
2024
Q1 | $6.18K | Buy |
334
+300
| +882% | +$5.55K | ﹤0.01% | 960 |
|
|
2023
Q4 | $1.07K | Buy |
+34
| New | +$1.07K | ﹤0.01% | 1222 |
|